New Results

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients

Paul F. McKay, Kai Hu, Anna K. Blakney, Karnyart Samnuan, Clément R. Bouton, Paul Rogers, Krunal Polra, Paulo J.C. Lin, Christopher Barbosa, Ying Tam, Robin J. Shattock
doi: https://doi.org/10.1101/2020.04.22.055608

Article usage

Article usage: April 2020 to July 2022

AbstractFullPdf
Apr 20205336561941
May 202024217801261
Jun 20201479342999
Jul 20201039129569
Aug 202039949221
Sep 202027334138
Oct 202024037168
Nov 202029933110
Dec 202024253142
Jan 2021222101143
Feb 202118892112
Mar 202117432105
Apr 202119139121
May 202113811102
Jun 202115718103
Jul 20212456192
Aug 202181838118
Sep 20216413089
Oct 20215151890
Nov 20213572557
Dec 20212142333
Jan 20222042439
Feb 2022129919
Mar 20221431353
Apr 20221621424
May 2022108523
Jun 2022105623
Jul 2022211
Back to top
Posted April 25, 2020.
Download PDF

Supplementary Material

Email
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients
Paul F. McKay, Kai Hu, Anna K. Blakney, Karnyart Samnuan, Clément R. Bouton, Paul Rogers, Krunal Polra, Paulo J.C. Lin, Christopher Barbosa, Ying Tam, Robin J. Shattock
bioRxiv 2020.04.22.055608; doi: https://doi.org/10.1101/2020.04.22.055608
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area